Cadmium is a well known environmental toxicant and carcinogen. To identify proteins involved in cellular adaptive responses to cadmium, we established cadmium-adapted U937 cells that exhibit resistance to cadmium-induced apoptosis, and we performed comparative proteome analysis of these cells with parental cells that were either untreated or treated with cadmium. Newly identified proteins that were changed in expression level in both adapted cells and cadmium-treated parental cells included proteins implicated in cell proliferation and malignant transformation. Most interesting, a calcium-binding protein calbindin-D 28k was increased only in the adapted cells but not in cadmium-exposed parental cells. The level of calbindin-D 28k increased by the degree of cadmium adaptation and was stably maintained without selective pressure of cadmium. Cadmium-adapted U937 cells were resistant to the toxic effects of cytosolic calcium rise by cadmium treatment and by depletion of intracellular calcium stores, suggesting that enhanced calcium buffering by up-regulated calbindin-D 28k may be responsible for acquiring resistance to cadmium-induced apoptosis. We demonstrated that overexpression of calbindin-D 28k in MN9D neuronal cells resulted in reduced cadmium-induced apoptosis. Our study documents for the first time that cells respond to long term cadmium exposure by increasing calbindin-D 28k expression, thereby attenuating cadmium-induced apoptosis.
age to cells leads to a complex series of events that can culminate in the death of the cells. To attenuate cadmium toxicity, cells respond by inducing a variety of genes and by modulating the expression levels or activities of proteins. These include proteins that (i) sequester cadmium to decrease the availability of this ion from interacting with cellular targets to elicit toxicity, such as metallothioneins (MT) 1 ; (ii) control GSH and related proteins to detoxify reactive oxygen species that are generated by cadmium; (iii) repair membrane and DNA damage; and (iv) renature or degrade unfolded proteins (3) . Cadmium can induce apoptosis in vivo and in vitro, as shown in cells of the respiratory system (4), the testis (5), the kidney (6), the liver (7) , and the immune system (8, 9) . Although a high dose of cadmium exposure of cells can induce apoptosis, low dose of cadmium stimulates DNA synthesis, cell proliferation, and malignant transformation (2) .
Upon repeated exposure of cells with increasing doses of cadmium, cells exhibit adaptive survival responses that have enabled many cells to become more resistant to subsequent high doses of cadmium. The cellular adaptation process involves the suppression of apoptosis induced by this metal. For example, cadmium-adapted alveolar epithelial cells, which have up-regulated expression of MT, GSH, and antioxidant enzymes, showed better protection against oxidant-induced apoptosis compared with the nonadapted cells (10) . In addition, cadmium-transformed prostate epithelial cell line exhibited down-regulated gene expression of caspases and pro-apoptotic Bax and up-regulation of anti-apoptotic BCL-2 gene, when compared with the nontumorigenic parental line (11) , suggesting that acquired resistance to apoptosis plays a role in cell transformation and malignant progression.
In the present study, in order to gain further insights into the mechanism for cellular long term survival response to cadmium, we have searched proteins associated with cadmium adaptation by the use of proteomics. Two cell lines of U937 cells were used for proteome comparison, a parental cell line and a cadmiumadapted cell line. The proteins were separated by two-dimensional gel electrophoresis for proteome analysis. Protein spots altered in cadmium-adapted cells were identified by peptide mass fingerprinting using matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF)-mass spectrometry. Remarkably, calbindin-D 28k was increased only in the adapted cells but not in parental cells treated with cadmium, suggesting that this protein is a secondary cadmium-responsive protein. Calbindin-D 28k has been known to possess an anti-apoptotic function by chelating calcium (12) (13) (14) (15) (16) . We demonstrated that the adapted cells showed better calcium buffering capacity than nonadapted cells, and its overexpression in neuronal cells protected cells from apoptosis induced by cadmium. Thus, increased expression of calbindinD 28k represents an adaptive survival mechanism that resists cadmium-induced apoptosis.
EXPERIMENTAL PROCEDURES
Reagents-All reagents used for cell culture were purchased from Invitrogen. Electrophoresis reagents including acrylamide solution (40%), Tris base, glycine, Immobiline DryStrip, IPG buffer, and IPG cover fluid were purchased from Amersham Biosciences. Trypsin (sequencing grade) was purchased from Promega (Madison, WI). Thapsigargin, Pluronic F-127, Fluo-2/AM, BTC-5N/AM and BAPTA-AM were from Molecular Probes (Eugene, OR). CdCl 2 , ionomycin, CHAPS, acetonitrile, trifluoroacetic acid, ␣-cyano-4-hydroxycinnamic acid, and other reagents were purchased from Sigma.
Cell Culture and Establishment of Cadmium-adapted U937 CellsThe human monocytic cell line U937 was obtained from the American Type Culture Collection (Manassas, VA). Cells were grown at 37°C with 5% CO 2 in RPMI 1640 medium supplemented with 2% sodium bicarbonate, 10% fetal bovine serum, 100 units/ml penicillin G, and 50 g/ml streptomycin. Cadmium-adapted cells were developed by stepwise exposure of parental U937 cells to cadmium with concentration ranging from 5 to 50 M. Cells surviving from the medium containing 5 M CdCl 2 were maintained for 2 weeks until normal growth rate was recovered. These cells were exposed to a subsequent higher concentration of cadmium that was increased by 5 M at each step. MN9D neuronal cells overexpressing calbindin-D 28k (MN9D/cal-D 28k ) were cultured as described (17) .
MTT Assay-Cell cytotoxicity induced by cadmium and other reagents was quantified by 3-(4,5-dimethylthiazol-2-y1)-2,5-diphenyltetrazolium bromide (MTT) reduction assay, as described previously (18) . Cells were seeded in 96-well plates (10 4 cells/well) 1 day before treatment. The cells were then treated with CdCl 2 for various times and concentrations. After incubation with the reagent, the cells were treated with 1 mg/ml MTT solution at a CO 2 incubator for 2 h at 37°C and lysed in 20% SDS in 50% aqueous dimethylformamide for 24 h. The absorbance of the dissolved formazan grains within the cells was measured at 540 nm in a microplate reader (Molecular Devices, Palo Alto, CA). Values from each treatment were calculated as percent cytotoxicity of the untreated control.
Flow Cytometric Assessment of Apoptosis-Phosphatidylserine externalization during cadmium-induced apoptosis in U937 cells was determined by two-color analysis of annexin V/FITC binding and propidium iodide (PI) uptake using flow cytometry (FACSCalibur, BD Biosciences) according to the instructions of the manufacturer. Annexin V-FITC detection kit and PI staining solution were purchased from BD Biosciences.
Two-dimensional Gel Electrophoresis and Image Analysis-Protein samples for two-dimensional gel electrophoresis were extracted as followed. Cells were lysed in extraction buffer (7 M urea, 2 M thiourea, 4% CHAPS, 40 mM Tris base, 20 mM DTT, 1 mM phenylmethylsulfonyl fluoride, and 1% IPG buffer) at 4°C for 30 min. The lysate was then centrifuged at 15,000 rpm for 30 min at 4°C. The supernatants were collected and treated with 250 units/ml endonuclease (Sigma) for 1 h at room temperature.
The first-dimensional isoelectric focusing (IEF) was performed on an IPGphor unit (Amersham Biosciences) using precasted 24-cm pH 4 -7 IPG gel strips. 2 mg of total proteins was dissolved to 350 l with rehydration buffer (7 M urea, 2 M thiourea, 2% CHAPS, 40 mM Tris base, 10 mM DTT, 0.02% bromphenol blue, and 1% IPG buffer) and rehydrated at 20°C for more than 12 h at 30 V. IEF was performed in a stepwise voltage increase procedure at 20°C to achieve a total of 100,000 V-h. After IEF separation, the gel strips were incubated with equilibration buffer (50 mM Tris, 6 M urea, 20% v/v glycerol, 2% w/v SDS, and 1% DTT) for 15 min followed by incubation in the same buffer with DTT replaced by 1.25% iodoacetamide (w/v) for an additional 15 min. The second dimension separation was performed on 1.0-mm-thick gradient polyacrylamide gels at 15 mA per gel at 10°C overnight using a DALT electrophoresis unit (Amersham Biosciences). The gels were stained with colloidal Coomassie Blue. The stained gels were scanned and analyzed using Melanie 3 software (GeneBio, Geneva, Switzerland).
In-gel Digestion for Protein Identification-Each excised gel spot was destained with 100 l of 50% acetonitrile in 25 mM ammonium bicarbonate (NH 4 HCO 3 ). The solution was replaced with a fresh aliquot, and the gel spots were incubated with shaking for 10 min at 37°C. The above washing and dehydration steps were repeated three times. After removal of the dehydration solution, gel spots were dried in a SpeedVac. The dried gel spots were incubated with 10 -15 l of 20 ng/l trypsin in 25 mM NH 4 HCO 3 on ice for 45 min, and then the supernatant was discarded and replaced with 25 mM NH 4 HCO 3 . The trypsin digestion was performed at 37°C for 14 -18 h. Peptides were first extracted using 0.1% trifluoroacetic acid, 50% acetonitrile at 37°C for 30 min, and the above procedure was repeated twice and then the peptides were extracted subsequently with 100% acetonitrile. The extracted solutions were dried in a Speed-Vac.
MALDI-TOF-Mass Spectrometry and Data Base Searching-The extracted peptides were dissolved in 0.1% trifluoroacetic acid, mixed with an equal volume of matrix solution (10 mg/ml ␣-cyano-4-hydroxycinnamic acid in 0.1% trifluoroacetic acid, 50% acetonitrile), and 1 l of the mixture was spotted onto a MALDI sample plate. Peptide mass spectra were obtained using an Applied Biosystem Voyager-DE STR MALDI-TOF mass spectrometer in the reflector mode. External calibration was carried out by using Sequazyme peptide mass standard kit (Perspective Biosystems) and internal calibration by using the autolytic peaks of trypsin. The protein identification was performed by searching the NCBInr protein data base using MS-Fit (prospector.ucsf.edu/). The criteria for searching were set at 50 ppm, at least four matching peptide masses, and theoretical molecular mass and pI matching estimated values from gels.
Western Blot Analysis-Cells were washed with PBS and lysed in SDS sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 5% 2-mercaptoethanol, 0.002% bromphenol blue, and 10% glycerol). The samples were boiled for 5 min and centrifuged at 12,000 rpm for 3 min, and equal amounts of proteins (20 -50 g) were separated by SDS-PAGE and transferred to nitrocellulose membranes. The membranes were blocked with TBS (10 mM Tris-HCl, pH 7.5, 150 mM NaCl) containing 5% nonfat milk for 1 h at room temperature and then incubated with various Abs for 1 h at room temperature. After they were washed with TBST (TBS plus 0.025% Tween 20), the membranes were incubated with the horseradish peroxidase-labeled secondary Ab for 1 h. After washing, the blots were treated with ECL reagents (Amersham Biosciences), followed by exposure to x-ray film. Abs used are anti-calbindin-D 28k Ab (Swant, Bellinzona, Switzerland), anti-caspase 3 Abs (murine-specific, Cell Signaling, Beverly, MA; human-specific, Santa Cruz Biotechnology, Santa Cruz, CA), anti-caspase-8 Ab (BD Biosciences), and mouse monoclonal PARP Ab (Roche Applied Science).
Measurement of the Level of Cytosolic Calcium and Cadmium-Cells for intracellular calcium measurements were preloaded with the cytosolic calcium indicator, 5 M Fura-2/AM plus 0.1% Pluronic F-127, for 30 min at room temperature and washed with RPMI 1640 (serum-and phenol red-free). Cells were resuspended in black opaque 96-well plates (2 ϫ 10 4 /well) in RPMI 1640 and treated with 20 or 50 M CdCl 2 for the times indicated at 37°C. Fluorescence was monitored on a Bio-Tek FL600 fluorescence absorbance spectrophotometer (Winooski, VT). The wavelength for excitation was 340 nm, and emission was measured at 510 nm. For intracellular cadmium measurement, cells exposed to cadmium for 1 h were processed as above using the heavy metal-specific fluorescent probe, BTC-5N/AM (1 M), instead of Fura-2/AM. The BTC-5N fluorescence was measured at a wavelength of 415 nm (excitation) and 500 nm (emission).
RESULTS

Cadmium-adapted U937 Cells Exhibit
Resistance to Apoptosis Induced by Cadmium-To study cellular adaptive responses to long term cadmium exposure, these metal-adapted U937 cells were established by exposing the cells to stepwise increased cadmium concentrations ranging from 5 to 50 M. Cadmium resistance of the adapted cell line was tested by MTT assay (Fig. 1A) . Upon treatment of cells with 20 and 50 M CdCl 2 , the nonadapted parental U937 cells showed 54 and 82% cytotoxicity after 24 h of exposure, respectively. In contrast, the cadmium-adapted cells showed only 5 and 14% cytotoxicity. Resistance to cadmium was also observed with longer treat-ment (48 h) in the adapted cells. Flow cytometric analysis using annexin V/FITC and PI double staining revealed that after 6 h of treatment with 50 M CdCl 2 , early apoptotic parental U937 cells (annexin V-positive, PI-negative) increased to 24.8%; as treatment time extended, the early apoptotic cells gradually decreased, whereas the cells in later stages of apoptosis (annexin V-positive and PI-positive) occupied the majority. Previous work by Li et al. (19) has indicated that these doublepositive U937 cells represent secondary necrotic cells whose membranes were damaged by cadmium. In cadmium-adapted cells, no significant time-dependent changes in apoptotic and secondary necrotic cell populations were observed, indicating that the adapted cells were resistant to cadmium-induced apoptosis and subsequent to the plasma membrane damage ( Caspase-3 and caspase-8 are suggested to be involved in cadmium-induced apoptosis of U937 cells (19) . We examined whether both caspases can be cleaved by cadmium treatment. Western blot analysis showed that in parental U937 cells, after 24 h of exposure to 50 M CdCl 2 , a significant decrease in both levels of procaspase-3 and -8 was observed. Although the cleaved product of caspase-3 (17 kDa) was visible at 6 h in parental cells, longer exposure of cadmium did not cause the increase of the band intensity. Rather, it became undetectable after 24 h of treatment, reflecting degradation of the cleaved form due to secondary necrotic death. In contrast, cadmiumadapted cells showed no apparent decrease in procaspase-3 and -8 levels after 24 h of exposure to cadmium, further confirming the apoptotic resistance of cadmium-adapted U937 cells (Fig. 1C) .
Proteome Analysis Associated with Cellular Cadmium Adaptation-To identify proteins associated with cadmium adaptation, protein expression patterns were compared in parental and cadmium-adapted cells by using two-dimensional gel electrophoresis. To ensure that proteins expressed differentially in the adapted cells resulted from the response to cadmium, twodimensional protein profiles were also compared with that of parental cells treated with 20 M CdCl 2 for 24 h. Fig. 2A shows the Coomassie Blue-stained two-dimensional protein pattern obtained after separation of 2-mg protein samples from the parental U937 cells. About 700 protein spots ranging from 10 to 100 kDa with pI values between 4 and 7 were detected. Fig. 2B is a comparative close-up view of six regions shown in Fig. 2A , where significant differences in protein expression level are marked. These protein spots were excised and subjected to trypsin digestion, MALDI-TOF mass spectra measurements, and data base searching with MS-Fit. Table I summarizes the identified proteins with quantitative alterations in cadmiumadapted cells and cadmium-treated parental cells, compared with untreated parental cells. The proteins commonly up-regulated in the adapted cells as well as cadmium-treated parental cells include retinaldehyde dehydrogenase 2, Rho GDP dissociation inhibitor-␣ (RhoGDI-␣), Ran-binding protein 1 (RanBP1), glutathione S-transferase, heterogeneous nuclear ribonucleoprotein C1/C2, c-Myc-binding protein MM1, and a hypothetical protein. Monocyte/neutrophil elastase inhibitor (MNEI) was identified as a down-regulated protein in both cadmium-adapted and cadmium-treated parental cells. Most interesting, protein levels of calbindin-D 28k and metastatic tumor antigen-1 short form (MTA-1s) were increased only in cadmium-adapted cells and not in cadmium-treated parental U937 cells.
Increased Expression of Calbindin-D 28k
Resulted from Long Term Adaptation of Cells to Cadmium-In the protein profiling data, the levels of calbindin-D 28k and MTA-1s were increased only in cells adapted to prolonged cadmium exposure, suggesting that their up-regulation may be the secondary consequence of cellular response to cadmium. We are particularly interested in calbindin-D 28k expression because it is a calcium-binding protein belonging to the calmodulin superfamily with six EF hands (20) . In many cell types, including U937 cells, cadmium exposure induced intracellular calcium increase, which is in part responsible for mediating the cadmium-induced apoptotic cell death (19) . In addition, calbindin-D 28k suppressed apoptosis induced by a variety of agents, and the death inhibitory action of calbindin-D 28k has been attributed to its ability to remove toxic calcium in cells (12) (13) (14) (15) (16) (21) (22) (23) (24) (25) . Thus, we predicted that calbindin-D 28k up-regulation of the adapted U937 cells is a part of the cellular responses to resist cadmiumevoked apoptosis. As a confirmatory experiment, we performed immunoblot analysis by using an anti-calbindin-D 28k Ab. The result showed that although the expression level of calbindin-D 28k was increased in cadmium-adapted cells, there was no change in calbindin-D 28k expression after 24 h of treatment of parental cells with 20 M CdCl 2 , which is consistent with the result obtained from the proteome analysis (Fig. 3A) . The elevated calbindin-D 28k expression was stably maintained even after culturing the cells in cadmium-free medium for at least 15 days (Fig. 3B) . The increased expression of calbindin-D 28k was also observed in independently established cadmium-adapted U937 cell lines, showing that cells adapted to higher concentrations of cadmium expressed higher levels of calbindin-D 28k (Fig. 3C) . Thus, during the cadmium adaptation process, cells appear to counteract the toxic effects of this metal by increasing the level of calbindin-D 28k . 
Cadmium-adapted U937 Cells Exhibit Better Calcium Buffering Capacity and Resistance to Death Induced by Intracellular Calcium
Overloading-In view of the calcium buffering function of calbindin-D 28k , it is likely that the elevation of this protein in the adapted cells may play a role in reducing the level of intracellular toxic calcium ion increased by cadmium. Therefore, we compared the changes in intracellular Ca 2ϩ concentration of cadmium-adapted and parental U937cells by using the cytosolic calcium indicator Fura-2/AM after exposure to cadmium. Fig. 4A shows the timedependent changes of fluorescence of Fura-2 in cells treated with 20 and 50 M CdCl 2 , revealing that the magnitude of increase in the intracellular ion concentrations induced by cadmium was significantly attenuated in cadmium-adapted cells. We also examined the effect of BAPTA-AM, a commonly used chelator of intracellular free Ca 2ϩ , on cadmium-induced apoptosis. Fig. 4B illustrates that parental cells pretreated with 20 M BAPTA-AM and subsequently stimulated with 50 M CdCl 2 for 24 h showed total inhibition of apoptosis, reducing the percentage of apoptotic cells (annexin V-positive) from 53.6 to 18.4%, which was almost equivalent to the percentage value of cadmium-unexposed control cells. As expected, the cadmium-adapted cells were resistant to apoptosis after treatment with 50 M CdCl 2 , and pretreatment of BAPTA-AM had no significant effect, suggesting that in the adapted cells the availability of free calcium ions necessary for cadmium-induced apoptosis is greatly reduced by the binding of calcium to the overexpressed calbindin-D 28k .
To acquire further evidence for the enhanced calcium buffering property of the adapted U937 cells, we tested whether they were better protected from toxicity triggered by intracellular calcium overloading than nonadapted cells. Administration of thapsigargin (the endoplasmic reticulum Ca 2ϩ -ATPase inhibitor) led to a massive increase in cytosolic Ca 2ϩ by efflux from vesicles in the endoplasmic reticulum (26) . Calcium ionophore (ionomycin) also caused an intracellular Ca 2ϩ rise that was caused by the release of cytosolic Ca 2ϩ stores and Ca 2ϩ influx. These treatments ultimately resulted in cell death in several cell types including U937 cells (27, 28) . MTT assays revealed that after 48 h of treatment with 10 -100 nM thapsigargin, the nonadapted U937 cells resulted in 36 -45% cytotoxicity, whereas the cadmium-adapted cells showed 13-24% cytotoxicity. The difference in the susceptibilities of these two cell lines was more conspicuous in response to ionomycin, in which addition of this reagent up to 1000 ng/ml was not toxic to the cadmium-adapted cells, rather promoting growth during the 48 h of exposure. However, the nonadapted parental cells exhibited ϳ40% cytotoxicity with 500 -1000 ng/ml ionomycin (Fig. 4C) . Taken together, our results indicate that cadmiumadapted cells are less sensitive to the disruption of intracellular calcium levels than nonadapted cells due to better calcium buffering capacity by up-regulated calbindin-D 28k .
Ectopic Expression of Calbindin-D 28k in a Neuronal Cell Line Reduces Cadmium Toxicity Mediated by Intracellular Calcium
Increase-Apart from calbindin-D 28k , other cadmium-response proteins such as MT, glutathione S-transferase, and anti-oxidant enzymes play roles in the protection of cadmium toxicity by modulating the level of the reactive oxygen species (2, 10, 29 -31). Therefore, the direct contribution of calbindin-D 28k in the resistance to cadmium toxicity has to be determined without the influence of these proteins. For this purpose, we have tried to establish U937 cells stably expressing calbindin-D 28k ; however, several attempts were unsuccessful because of high lysosomal enzymatic activities in this particular cell type. Instead, we took advantage of using a dopaminergic neuronal MN9D cell line that was permanently transfected with the plasmid expressing calbindin-D 28k (17) , and we investigated whether overexpression of calbindin-D 28k per se can protect against apoptosis induced by cadmium. The MN9D/cal-D 28k cells showed a high level of calbindin-D 28k expression compared with the control vector-transfected MN9D/neo cells (Fig.  5A) . The MTT assay was done to compare the cytotoxic effect of cadmium on these cells (Fig. 5B) . After treatment of MN9D/neo cells with 1 M CdCl 2 , the percentage of cytotoxicity increased by 28% at 24 h and by 67% at 48 h. In contrast, MN9D/cal-D 28k cells exhibited significantly less cytotoxicity than MN9D/neo cells (12 and 28% cytotoxicity at each respective time period). 24 h of exposure to 10 M CdCl 2 resulted in 67% cytotoxicity in MN9D/neo cells, whereas calbindin-D 28k -expressing cells were still more tolerant, exhibiting 43% cytotoxicity. Further incubation of cells over 48 h resulted in complete cell death in both cell lines. The results indicate that MN9D cells are highly sensitive to cadmium, and calbindin-D 28k has a protective function, although it cannot completely block cell damage caused by this metal.
Experiments for examining the effect of BAPTA-AM in cadmium toxicity of MN9D cells revealed that a brief exposure of this reagent in MN9D/neo cells decreased cadmium cytotoxicity from 71 to 25%, indicating that cadmium-induced calcium increase is responsible for cellular toxicity in this cell type. On the other hand, in MN9D/cal-D 28k cells, which exhibited less cytotoxicity (47%) than MN9D/neo cells, pretreatment of BAPTA-AM caused total inhibition of the cadmium toxicity, suggesting an additive effect of BAPTA-AM and calbindin-D 28k on the removal of intracellular toxic calcium ion (Fig. 5C ). The enhanced calcium buffering capability of MN9D/cal-D 28k cells was evident from the results showing that after 24 h of exposure to 10 M CdCl 2 , the increase of Fura-2 fluorescence in MN9D/cal-D 28k cells was significantly diminished as compared with that of MN9D/neo cells (1.9-versus 3.4-fold increase over the respective untreated control) (Fig. 5D, left) . When cadmium influx into cells was measured by using a cell-permeable, cadmium-specific fluorescent dye (BTC-5N/AM) (32), no considerable difference in the increase of intracellular Cd 2ϩ concentration was observed in MN9D/neo and MN9D/cal-D 28k cells (Fig.  5D, right) . These results suggest that both cell lines can take up cadmium with similar efficiency and that the ectopically expressed calbindin-D 28k may not bind cadmium as efficiently as calcium in vivo, although it has been shown that cadmium was the potent inhibitor for calcium binding in in vitro experiments using the purified calbindin-D 28k (33) .
Evidence That Calbindin-D 28k Plays a Protective Role in Cadmium-induced Apoptosis-To confirm further the tolerance of MN9D/cal-D 28k cells to cadmium-induced apoptosis, we compared the cleavage kinetics of caspase-3 and its substrate PARP (Fig. 6) . Western blot analysis using the polyclonal antibody of mouse caspase-3 showed that in MN9D/neo cells, the cleaved caspase-3 product (19 kDa) was evident after 8 h of exposure to 10 M CdCl 2 , and the maximum amount of the cleaved product was detected between 16 and 18 h of exposure. In contrast, MN9D/cal-D 28k cells showed a much delayed appearance of the cleaved product. Similar delayed cleavage kinetics of PARP were observed in MN9D/cal-D 28k cells. These results clearly showed that overexpression of calbindin-D 28k per se can confer resistance to cadmium-induced apoptosis in the dopaminergic neuronal cells. Based on the results obtained from MN9D cells overexpressing calbindin-D 28k , we concluded that the elevated expression of calbindin-D 28k in cadmiumadapted U937 cells, at least in part, played a role in protection from this metal-induced apoptosis. DISCUSSION We employed the proteomics approach to identify proteins that are involved in the cellular adaptive response to cadmium toxicity. To this end, we established the cadmium-adapted U937 cells that exhibited tolerant phenotypes against cadmium-induced apoptosis. Comparative analysis of proteome profiles between the parental and cadmium-adapted cells allowed the identification of 12 proteins whose steady-state levels were altered in the cadmium-adapted cells. Most of the identified proteins were bona fide cadmium-responsive proteins because altered expression was observed in both cadmium-adapted cells and cadmium-treated parental cells. In addition, we found that two proteins including calbindin-D 28k were not up-regulated in parental cells treated with cadmium, but their steady-state level was increased in cadmium-adapted cells, representing them as secondary cadmium-responsive proteins.
Some of the proteins identified in this study may be related to the role of cadmium in cell proliferation and malignant transformation. These include RanBP1, RhoGDI-␣, and c-Mycbinding protein MM-1. It has been well established that low doses (micromolar ranges) of cadmium can stimulate DNA synthesis, cell proliferation, and malignant transformation (2, 34, 35) . In particular, studies done by Misra et al. (34) demonstrated that the Ras-dependent mitogen-activated protein kinase signaling limb is of critical importance in the initiation of cadmium-mediated mitogenesis in macrophages. RanBP1 and RhoGDI-␣ are proteins that regulate the activity of Ras-like small GTP-binding proteins, Ran and Rho, respectively. RanBP1 binds directly to the GTP-bound Ran and enhances the activity of Ran GTPase-activating protein 1. The regulated RanBP1 activity is shown to be required for proper execution of mitosis in somatic cells (36) . RhoGDI-␣ is an inhibitor of Rho that plays an important role in cellular processes such as cell morphology, proliferation, malignant transformation and metastasis, and apoptosis (37) . Additionally, a putative cadmiumresponsive protein MM-1 has been proposed as a tumor suppressor that controls the transcriptional activity of c-Myc (38) . Previous studies (39) have shown that cadmium treatment alters the expression of c-Myc protein in a variety of cell types and that cadmium-induced cell transformation and tumorigenesis may be associated with transcriptional activation of protooncogenes, including c-myc. More study is necessary to elucidate possible involvement of RanBP1, RhoGDI-␣, and MM-1 in the cadmium-induced carcinogenesis.
MNEI was found to be down-regulated in cadmium-adapted U937 cells and also in response to short term cadmium exposure of the nonadapted cells. MNEI is a 42-kDa serpin (a serine protease inhibitor) superfamily protein characterized initially as a fast-acting inhibitor of neutrophil elastase. Cadmium, which is present in cigarette smoke, is associated with the development of emphysema and lung cancer. It has been suggested that neutrophils, acting in part via the proteolytic activities of neutrophil elastase, play a pivotal role in the development of emphysema. For example, a synthetic neutrophil elastase inhibitor (ZD0892) could prevent or reduce emphysema in guinea pigs exposed to cigarette smoke acutely or daily for 6 months (40). The neutrophil elastase-deficient mice were significantly protected from the long term cigarette smokeinduced emphysema compared with wild-type littermate controls (41) . Therefore, it is tempting to speculate that cadmiuminduced down-regulation of natural inhibitors of neutrophil elastase MNEI may contribute in part to the inflammatory and destructive effects of cigarette smoke leading to emphysematous lung destruction.
Unlike the primary cadmium-responsive proteins described above, MTA-1s and calbindin-D 28k were up-regulated only in cadmium-adapted resistant cells but not in cadmium-treated parental cells. Therefore, these proteins can be classified as secondarily acquired cadmium-responsive proteins. Concerning the increased expression of calbindin-D 28k in cadmiumadapted U937 cells, we confirmed this by Western blot analysis (Fig. 3A) . Cells adapted to long term repeated exposure to increasing doses of cadmium led to the concomitant elevation of calbindin-D 28k expression, as evident from the detection of higher levels of calbindin-D 28k in cells adapted to higher concentrations of cadmium (Fig. 3C) . Its up-regulation was not the result of direct transcriptional activation by cadmium. Recently, cadmium has been reported to induce genes regulating translation initiation, such as translational initiation factor 3 (TIF3) and translation elongation factor-1␦ (TEF-1␦) (42, 43) . Overexpression of these genes in mammalian cells resulted in transformation and tumorigenesis, and their inhibition in the cadmium-transformed BALB/c-3T3 cells by antisense mRNAs caused a significant reversal of the transformed phenotype, suggesting that the overall increase in the rate of protein synthesis by these translation factors may in part be responsible for cadmium-induced cell transformation and tumorigenesis. Whether the observed overexpression of calbindin-D 28k resulted from the increase in the overall translation rate mediated by the overexpression of human TIF3 and TEF-1␦ in cadmium-adapted cells requires additional studies.
As a member of calmodulin superfamily, calbindin-D 28k can modulate calcium homeostasis and can protect cells from calcium-mediated apoptosis induced by a variety of apoptotic stimuli (23-25, 44, 45) . In particular, Bellido et al. (21) have shown that the anti-apoptotic properties of calbindin-D 28k may result not only from calcium buffering but also from the ability of the protein to interact with and to inhibit caspase-3, a property that is independent of its calcium binding capability. Several studies (11, 46 -48) have indicated that cadmium exposure results in a rapid and sustained intracellular calcium elevation, followed by caspase-3 activation that leads to cell death. In U937 cells, cadmium induces apoptosis via two independent pathways, the calcium-calpain-dependent pathway and the caspase-mitochondria-dependent pathway (19) . Therefore, this calcium buffering and/or direct caspase-3 inhibitory effects of calbindin-D 28k may account for the cadmium resistance of the adapted U937 cells. In the present study, we have provided strong evidence in support of this notion, based on the following observations. (i) Cadmium-adapted U937 cells were more resistant to apoptosis induced by intracellular calcium overloading. (ii) Disruption of the intracellular calcium level by BAPTA-AM had a significant blocking effect on cadmium-induced apoptosis of the nonadapted cells but showed little effect on the adapted cells because of the reduced level of available free calcium ions. These results suggest that increased expression of calbindin-D 28k in cadmium-adapted U937 cells can be attributed to its calcium buffering effect during cadmium-induced apoptosis. Finally, we demonstrated that neuronal cells stably transfected with the plasmid expressing calbindin-D 28k exhibited less susceptibility to cadmium-induced, calcium-dependent apoptosis and a much more delayed caspase-3 activation and PARP cleavage than cells transfected with the control plasmid, providing direct evidence that calbindin-D 28k contributes to the acquisition of resistance to apoptosis induced by cadmium. It is worthwhile to note that in MN9D/neo cells the cleaved product of caspase-3 was easily detectable, and its amount was increased as cadmium exposure time was extended. On the other hand, in U937 cells the cleaved product was not easily detectable, but the proform of caspase-3 was degraded at a later stage of apoptosis, as it was in the degradation of caspase-8 by cadmium (Fig. 1C) . These results suggest that for the initiation of apoptosis in U937 cells, cadmium may use a more preferentially calcium-calpain-dependent pathway than caspase-mitochondria-dependent pathway, and at the late stage of apoptosis caspase-3 and caspase-8 may be activated as a secondary consequence of apoptosis, which may eventually result in necrotic cell death.
Calbindin-D 28k has been shown to have a higher affinity for binding cadmium than any other divalent cations (33) . This direct cadmium binding property of calbindin-D 28k may also offer protection from apoptosis. However, the level of intracellular free cadmium was not much reduced in MN9D cells overexpressing calbindin-D 28k compared with MN9D/neo cells (Fig. 5D) , suggesting that the direct cadmium binding by calbindin-D 28k may not contribute much to protection from cadmium-induced apoptosis in this neuronal cell type. It is likely that the anti-apoptotic function of calbindin-D28k can be attributed to reducing the intracellular toxic calcium level that is increased by cadmium rather than its direct cadmium sequestering effect. The detailed mechanisms by which calbindin-D 28k protects cells against cadmium-induced apoptosis await future investigation.
In conclusion, our study focuses on the cellular adaptive responses to long term cadmium exposure. An increase in the expression of Rho GDI-␣, RanBP1, and c-Myc-binding protein MM-1 in cadmium-adapted cells suggests the involvement of these proteins in the metal-induced mitogenesis and cell proliferation. Of interest is that acquisition of cadmium resistance was partly caused by an increased expression of calbindin-D 28k , which enables cells to escape from cadmium-induced apoptosis. Because calbindin-D 28k is overexpressed in various cancer cells (19, 24, 49) , it seems reasonable to predict that the elevation of this protein could promote neoplastic cell survival as well as subsequent clonal expansion and tumor development. Unveiling the precise mechanisms of this protein in rescuing cells from cadmium-mediated apoptosis may shed light on the understanding of cadmium-mediated carcinogenesis.
